Vnitr Lek 2005, 51(10):1068-1069

Význam L-karnitinu u pacientů s chronickým renálním selháním léčených hemodialýzou - editorial

V. Teplan
Klinika nefrologie IKEM, Praha, přednosta prof. MUDr. Vladimír Teplan, DrSc.

Received: February 22, 2005; Published: October 1, 2005  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Teplan V. Význam L-karnitinu u pacientů s chronickým renálním selháním léčených hemodialýzou - editorial. Vnitr Lek. 2005;51(10):1068-1069.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Bellinghieri G, Santoro D, Calvani M et al. Carnitine and hemodialysis. Am J Kidney Dis 2003; 41(Suppl 1): S116-S122. Go to original source... Go to PubMed...
    2. Eknoyan G, Latos L, Lindberg J Practice recommendations for the use of L-carnitine in dialysis-related carnitine disorder. Am J Kidney Dis 2003; 41: 868-876. Go to original source... Go to PubMed...
    3. Evans AM, Faull RA, Nation RL et al. Impact of hemodialysis on endogenous plasma and muscle carnitine levels in patients with end-stage renal disease. Kidney Int 2004; 66: 1527-1534. Go to original source... Go to PubMed...
    4. Golper TA, Goral S, Becker BN et al. L-carnitine treatment of anemia. Am J Kidney Dis 2003; 41 (Suppl 4): S27-S34. Go to original source... Go to PubMed...
    5. Goral S. Levocarnitine and muscle metabolism in patients with end-stage renal disease. J Ren Nutr 1998; 8: 118-121. Go to original source... Go to PubMed...
    6. Hoppel C. The role of carnitine in normal and altered fatty acid metabolism. Am J Kidney Dis 2003; 41(Suppl 4): S4-S12. Go to original source... Go to PubMed...
    7. Schreiber B. Management of carnitine deficiency in ESRD patients undergoing dialysis: challenges and considerations. Dialysis Transplantation 2001; 30: 120-125.
    8. Šteidl L, Zbránková B. Význam karnitinu a jeho posouzení v medicíně. Praha: Triton 2000.
    9. Teplan V. Metabolismus a ledviny. Praha: Grada Publishing 2000.
    10. Veselá E, Racek J, Trefil L et al. Effect of L-carnitine supplementation in hemodialysis patients. Nephron 2001; 88: 218-223. Go to original source... Go to PubMed...

    Return to the content


    Vnitřní lékařství

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.